• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地方性多重耐药革兰氏阴性杆菌引起的感染:对头孢西丁的敏感性及治疗

Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.

作者信息

Alford R H

机构信息

Medical Service, Veterans Administration Hospital, Nashville, Tennessee 37203.

出版信息

Rev Infect Dis. 1979 Jan-Feb;1(1):175-82. doi: 10.1093/clinids/1.1.175.

DOI:10.1093/clinids/1.1.175
PMID:400932
Abstract

A nosocomial outbreak of infections due to bacteria resistant to multiple antibiotics evolved into an endemic prevalence of several antibiotic-resistant gram-negative rods. The resistance of these bacteria to available beta-lactam antibiotics, a variety of broad-spectrum agents, and available aminoglycosides other than amikacin led to an evaluation of cefoxitin, a beta-lactamase-resistant cephamycin. Most multiply resistant isolates of Klebsiella pneumoniae, Serratia marcescens, and Proteus mirabilis were sensitive to cefoxitin in vitro. Cefoxitin therapy of 11 severe nosocomial infections caused by multiply resistant K. pneumoniae resulted in clinical and bacteriologic cure in seven patients.

摘要

由对多种抗生素耐药的细菌引起的医院感染暴发演变成了几种耐抗生素革兰氏阴性杆菌的地方性流行。这些细菌对现有的β-内酰胺类抗生素、多种广谱药物以及除阿米卡星之外的现有氨基糖苷类抗生素具有耐药性,这促使人们对一种耐β-内酰胺酶的头孢霉素——头孢西丁进行评估。大多数多重耐药的肺炎克雷伯菌、粘质沙雷氏菌和奇异变形杆菌分离株在体外对头孢西丁敏感。对11例由多重耐药肺炎克雷伯菌引起的严重医院感染进行头孢西丁治疗,结果7例患者实现了临床和细菌学治愈。

相似文献

1
Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.地方性多重耐药革兰氏阴性杆菌引起的感染:对头孢西丁的敏感性及治疗
Rev Infect Dis. 1979 Jan-Feb;1(1):175-82. doi: 10.1093/clinids/1.1.175.
2
Nosocomial gram-negative bloodstream isolates: a comparison of in vitro antibiotic potency.医院获得性革兰氏阴性血流分离株:体外抗生素效力比较
J Hosp Infect. 1989 Oct;14(3):217-25. doi: 10.1016/0195-6701(89)90038-8.
3
Cefoxitin and cephamycins: microbiological studies.头孢西丁与头霉素类:微生物学研究
Rev Infect Dis. 1979 Jan-Feb;1(1):73-89. doi: 10.1093/clinids/1.1.73.
4
[Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].[新型耐β-内酰胺酶头孢霉素抗生素头孢西丁与头孢噻吩、头孢噻啶和头孢唑林的微生物学评价]
Fortschr Med. 1978 Aug 10;96(30):1510-7.
5
[Susceptibility of gram-negative bacterial isolates to six beta-lactam and two aminoglycoside antibiotics at our university hospital].[我校附属医院革兰氏阴性菌分离株对六种β-内酰胺类抗生素和两种氨基糖苷类抗生素的敏感性]
J UOEH. 1988 Sep 1;10(3):297-303. doi: 10.7888/juoeh.10.297.
6
Current status of therapy with cefoxitin.头孢西丁的治疗现状
Clin Ther. 1980;3(2):66-79.
7
Resistance patterns among nosocomial pathogens: trends over the past few years.医院病原体的耐药模式:过去几年的趋势
Chest. 2001 Feb;119(2 Suppl):397S-404S. doi: 10.1378/chest.119.2_suppl.397s.
8
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.头孢西丁,一种半合成头孢霉素抗生素:抗菌谱及对革兰氏阴性β-内酰胺酶水解的抗性。
Antimicrob Agents Chemother. 1974 Aug;6(2):170-6. doi: 10.1128/AAC.6.2.170.
9
A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.头孢西丁和头孢噻吩对7312株临床分离菌的体外活性比较。
Chemotherapy. 1981;27(4):239-46. doi: 10.1159/000237986.
10
Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.头孢西丁对多重耐药肺炎克雷伯菌的体外活性。
Antimicrob Agents Chemother. 1977 Jan;11(1):84-7. doi: 10.1128/AAC.11.1.84.